Physiological impact of high-flow nasal cannula therapy on postextubation acute respiratory failure after pediatric cardiac surgery: a prospective observational study
Open Access
- 6 June 2017
- journal article
- research article
- Published by Springer Nature in Journal of Intensive Care
- Vol. 5 (1) , 1-5
Abstract
Reintubation after pediatric cardiac surgery is associated with a high rate of mortality. Therefore, adequate respiratory support for postextubation acute respiratory failure (ARF) is important. However, little is known about the physiological impact of high-flow nasal cannula (HFNC) therapy on ARF after pediatric cardiac surgery. Our working hypothesis was that HFNC therapy for postextubation ARF after pediatric cardiac surgery improves hemodynamic and respiratory parameters. This was a prospective observational study conducted at a single university hospital. Children less than 48 months of age who had postextubation ARF after cardiac surgery were included in this study. HFNC therapy was started immediately after diagnosis of postextubation ARF. Data obtained just before starting HFNC therapy were used for pre-HFNC analysis, and data obtained 1 h after starting HFNC therapy were used for post-HFNC analysis. We compared hemodynamic and respiratory parameters between pre-HFNC and post-HFNC periods. The Wilcoxon signed-rank test was used to analyze these indices. Twenty children were included in this study. The median age and body weight were 4.5 (2.3–14.0) months and 4.3 (3.1–7.1) kg, respectively. Respiratory rate (RR) significantly decreased from 43.5 (32.0–54.8) to 28.5 (21.0–40.5) breaths per minute (p = 0.0008) 1 h after the start of HFNC therapy. Systolic blood pressure also decreased from 87.5 (77.8–103.5) to 76.0 (70.3–85.0) mmHg (p = 0.003). Oxygen saturation, partial pressure of arterial carbon dioxide, heart rate, and lactate showed no remarkable changes. There was no adverse event caused by HFNC therapy. HFNC therapy improves the RR of patients who have postextubation ARF after pediatric cardiac surgery without any adverse events.Keywords
Funding Information
- MEXT/JSPS KAKENHI (Grant Number JP26861233)
This publication has 20 references indexed in Scilit:
- High-flow nasal cannula therapy for infants with bronchiolitisCochrane Database of Systematic Reviews, 2014
- High-Flow Nasal Prong Oxygen Therapy or Nasopharyngeal Continuous Positive Airway Pressure for Children With Moderate-to-Severe Respiratory Distress?*Pediatric Critical Care Medicine, 2013
- The Critically Ill Pediatric Hematopoietic Stem Cell Transplant PatientPediatric Critical Care Medicine, 2013
- Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literatureIntensive Care Medicine, 2012
- Non-Invasive Ventilation in Acute Respiratory Failure in ChildrenPediatric Reports, 2012
- Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patientsBritish Journal of Anaesthesia, 2011
- Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen deliveryIntensive Care Medicine, 2011
- Predictive factors for the outcome of noninvasive ventilation in pediatric acute respiratory failure*Pediatric Critical Care Medicine, 2010
- Effect of Low Flow and High Flow Oxygen Delivery on Exercise Tolerance and Sensation of DyspneaChest, 1994
- Nasal and Oral Flow-Volume Loops in Normal Subjects and Patients with Obstructive Sleep ApneaAmerican Review of Respiratory Disease, 1990